ADMA Biologics
Yahoo Finance • 23 hours ago
ADMA Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA) resulting from alle... Full story
Yahoo Finance • yesterday
Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating ADMA Biologics (NASDAQ: ADMA) (“ADMA Biologics” or the “Company”) for potential vi... Full story
Yahoo Finance • 9 days ago
Here’s What Analysts Think About ADMA Biologics (ADMA)
ADMA Biologics, Inc. (NASDAQ:ADMA) is one of the best small cap stocks to buy for 10x potential. On May 7, Mizuho lowered the price target on ADMA Biologics, Inc. (NASDAQ:ADMA) to $20 from $24 while maintaining an Outperform rating on the... Full story
Yahoo Finance • 10 days ago
חדשות למשקיעים ב-ADMA: אם סבלתם הפסדים ב-ADMA Biologics, Inc (נאסד"ק: ADMA), אתם מוזמנים ליצור קשר עם משרד רוזן עורכי הדין בנוגע לזכויותיכם
ניו יורק, May 14, 2026 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מודיע על חקירה של תביעות ניירות ערך פוטנציאליות מטעם בעלי המניות של ADMA Biologics, Inc (נאסד"ק: ADMA)... Full story
Yahoo Finance • 12 days ago
$ADMA Investigation Reminder: ADMA Biologics Investigation on behalf of Investors is Ongoing – Contact BFA Law if You Lost Money
NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws. If you investe... Full story
Yahoo Finance • 15 days ago
$ADMA Investor News: ADMA Biologics Stock Drops 29% Amid Channel Stuffing Claims Triggering Securities Fraud Investigation – Contact BFA Law if You Suffered Losses
NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws. If you investe... Full story
Yahoo Finance • 17 days ago
BREAKING: ADMA Biologics Shares Fall Over 24%; Investors Encouraged to Contact Block & Leviton to Possibly Recover Losses
BOSTON, May 06, 2026 (GLOBE NEWSWIRE) -- Block & Leviton is investigating ADMA Biologics, Inc. (Nasdaq: ADMA) for potential securities law violations. Investors who have lost money in their ADMA Biologics, Inc. investment should contact... Full story
Yahoo Finance • 22 days ago
Investor Notice: ADMA Biologics (NASDAQ:ADMA) may have Committed Securities Fraud after Channel Stuffing Claims Disclosed – Contact BFA Law about the Pending Investigation
NEW YORK, May 01, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws. If you investe... Full story
Yahoo Finance • 23 days ago
ADMA Biologics Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA) resulting fr... Full story
Yahoo Finance • 29 days ago
ADMA Legal Notification: ADMA Biologics Securities Class Action Investigation Ongoing – Investors with Losses after 29% Stock Drop Notified to Contact BFA Law
NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws. If you inves... Full story
Yahoo Finance • last month
$ADMA Investigation: BFA Law Notifies ADMA Biologics Investors that Lost Money after 29% Stock Drop of Ongoing Securities Fraud Investigation
NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws. If you inves... Full story
Yahoo Finance • last month
ADMA Securities News: ADMA Biologics Hit with Securities Fraud Investigation after Channel Stuffing Claims Trigger 29% Stock Drop – Investors Urged to Contact BFA Law
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws. If you inves... Full story
Yahoo Finance • last month
ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.
NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a top complex litigation law firm, is investigating ADMA Biologics (NASDAQ: ADMA) (“ADMA Biologics” or the “Company”) for potential violations of the federal securities... Full story
Yahoo Finance • last month
$ADMA Legal News: ADMA Biologics Investors may have been Affected by Fraud after Channel Stuffing Claims Disclosed – Contact BFA Law if You Lost Money
NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws. If you inves... Full story
Yahoo Finance • last month
$ADMA Investigation Reminder: ADMA Biologics Investors are Reminded to Contact BFA Law after Company Investigated for Securities Fraud Over Channel Stuffing Claims
NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws. If you inves... Full story
Yahoo Finance • last month
Cantor Fitzgerald Downgrades ADMA Biologics (ADMA) to Neutral, Here’s Why
ADMA Biologics, Inc. (NASDAQ:ADMA) is one of the Best Growth Stocks to Buy With Highest Upside Potential. On March 26, Cantor Fitzgerald analyst Kristen Kluska downgraded ADMA Biologics, Inc. (NASDAQ:ADMA) from Overweight to Neutral, witho... Full story
Yahoo Finance • last month
Mid-cap healthcare stocks with A grade EPS revisions ahead of earnings
[Heart Health Concept] Eoneren/E+ via Getty Images As Q1 2026 earnings season approaches, the healthcare sector enters reporting season as one of the market's primary laggards, with the Health Care Select Sector SPDR Fund (XLV [https://se... Full story
Yahoo Finance • 2 months ago
Shareholder News: ADMA Biologics (NASDAQ:ADMA) Drops 29% Amid Channel Stuffing Claims Triggering Securities Fraud Investigation – Investors Urged to Contact BFA Law
NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws. If you inves... Full story
Yahoo Finance • 2 months ago
$ADMA Stock News: ADMA Biologics Investigated for Securities Fraud Following Channel Stuffing Claims – Investors Notified to Contact BFA Law
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws. If you inves... Full story
Yahoo Finance • 2 months ago
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating
SAN FRANCISCO, April 01, 2026 (GLOBE NEWSWIRE) -- Investors in ADMA Biologics, Inc. (NASDAQ: ADMA) saw the price of their shares slide over 16% on March 24, 2026 on short seller Culper Research’s report, “ADMA Biologics Inc. (ADMA): Chan... Full story